Both in Pharmaceuticals
Immunic vs Perspective Therapeutics
Over the past year IMUX returned +4.5% and CATX returned −65.3%; their daily moves had a correlation of 0.08.
IMUX +4.5% CATX −65.3%Growth of $1, one year, split-adjusted
| Metric | IMUX | CATX |
|---|---|---|
| Price | $7.82 | $0.9035 |
| Market cap | $106.7M | $103.1M |
| Today | +2.89% | +2.67% |
| 1 month | 0.0% | −61.7% |
| 6 months | −29.0% | −76.3% |
| Year to date | +46.5% | −67.1% |
| 1 year | +4.5% | −65.3% |
| Revenue growth (YoY) | — | −72.1% |
| Gross margin | — | 100.0% |
| Net margin | — | −33069.1% |
| P/E (TTM) | — | — |
| Price / sales | — | 252.2× |
| Net cash | $155.1M | $235.3M |
| Dividend yield | — | — |
| Volatility (60d) | 73.1% | 117.5% |
| Short % of float | 17.5% | 17.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).